NCT05648474

Brief Summary

This study is designed to evaluate the clinical utility of a known intraoperative neuromonitoring modality (SSEP) using saphenous nerve as the site of stimulation to identify changes to the lumbar nerves which may be at risk during the lateral lumbar interbody fusion (LLIF) procedure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 13, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 13, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

October 24, 2024

Status Verified

October 1, 2024

Enrollment Period

3.1 years

First QC Date

December 5, 2022

Last Update Submit

October 22, 2024

Conditions

Keywords

SpineSurgeryAdultNeuromonitoringElectromyographySomatosensory evoked potentials

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and specificity of SSEP neuromonitoring in post-operative clinical diagnosis of motor/sensory deficits

    This outcome measure determines the utility of the saphenous nerve SSEP monitoring based on the correlation of intraoperative neuromonitoring results with new or worsened postoperative neural deficits, as measured by motor and sensory physical exam.

    6 weeks or until new or worsened neural deficits are resolved, but not exceeding 12 months.

Secondary Outcomes (1)

  • Determination of the positive predictive value (PPV) and negative predictive value (NPV) of free run and SSEP monitoring modalities.

    6 weeks or until new or worsened neural deficits are resolved, but not exceeding 12 months.

Study Arms (1)

Adult undergoing 1- or 2-level lateral lumbar interbody fusion surgery, inclusive of the L4-5 level

Diagnostic Test: Somatosensory evoked potential [SSEP] intraoperative monitoring

Interventions

No study specific intervention is performed. Intraoperative neuromonitoring system that is observed in this study is for assessing the health of the lumbar plexus during lateral lumbar interbody fusion surgery

Adult undergoing 1- or 2-level lateral lumbar interbody fusion surgery, inclusive of the L4-5 level

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of both sexes undergoing LLIF surgery atone or two levels inclusive of the L4-5 level.

You may qualify if:

  • At least 18 years of age at the time of planned surgery.
  • Indicated for 1- or 2-level instrumented LLIF surgery (in either prone or lateral decubitus positions), inclusive of the L4-5 disc space.
  • Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.

You may not qualify if:

  • Patients requiring surgical treatment at more than 2 lumbar levels.
  • Patients with peripheral neuropathy such as from diabetes or other conditions that might affect the reliability of intraoperative neuromonitoring.
  • Patients with prior history of partial/full hip or knee joint replacement surgery (i.e., arthroplasty or resurfacing) on the leg targeted for saphenous monitoring and electrode placement.
  • Patients with presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  • Female patients who are pregnant or wanting to become pregnant during the timeframe of study participation.
  • Patients participating in another clinical study which may compromise this study's results or compliance with this study's procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alphatec Spine Inc.

Carlsbad, California, 92008, United States

RECRUITING

MeSH Terms

Conditions

Intervertebral Disc DegenerationSpinal StenosisSpondylolisthesis

Interventions

Evoked Potentials, SomatosensoryMonitoring, Intraoperative

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesSpondylolysisSpondylosis

Intervention Hierarchy (Ancestors)

Evoked PotentialsCortical ExcitabilityElectrophysiological PhenomenaPhysiological PhenomenaNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaMonitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosisSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2022

First Posted

December 13, 2022

Study Start

July 13, 2022

Primary Completion

August 28, 2025

Study Completion

December 31, 2025

Last Updated

October 24, 2024

Record last verified: 2024-10

Locations